tRNS for ADHD
What You Need to Know Before You Apply
What is the purpose of this trial?
A randomized, sham-controlled, double-blind clinical trial to examine the safety and effectiveness of tRNS on unmedicated pediatric patients (7-12 years) with ADHD. Subjects will undergo either tRNS or sham treatment for 10 days during a two-week period in a home-simulated environment. Each treatment session is 20 minutes, during which their attention will be maintained using a software game.
Will I have to stop taking my current medications?
Yes, you must stop taking any medications that affect the central nervous system, including ADHD medications, at least 7 days before joining the trial.
Is transcranial random noise stimulation (tRNS) safe for humans?
Research on transcranial random noise stimulation (tRNS) shows it is generally safe, with no significant adverse events reported in studies, including those involving children with ADHD. Some participants experienced longer times to fall asleep and more wake-ups, but overall, tRNS is considered a non-invasive and safe technique.12345
How is the treatment tRNS for ADHD different from other treatments?
Transcranial random noise stimulation (tRNS) is a unique, non-invasive brain stimulation technique that uses random electrical currents to potentially improve ADHD symptoms when combined with cognitive training. Unlike traditional medications, tRNS directly targets brain activity and may lead to long-term benefits by engaging brain plasticity mechanisms.12346
What data supports the effectiveness of the treatment tRNS for ADHD?
Who Is on the Research Team?
Paul Croarkin
Principal Investigator
Mayo Clinic
Eric Storch
Principal Investigator
Baylor College of Medicine
Are You a Good Fit for This Trial?
This trial is for children aged 7-12 with ADHD who haven't taken medication for it. They'll be part of a study where they receive tRNS, a noninvasive brain stimulation, while playing a game to help focus their attention.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants undergo either tRNS or sham treatment for 10 days during a two-week period in a home-simulated environment. Each session is 20 minutes.
Follow-up 1
Participants are monitored for changes in ADHD symptom severity and adverse events.
Follow-up 2
Further monitoring of ADHD symptom severity and adverse events.
What Are the Treatments Tested in This Trial?
Interventions
- tRNS
Find a Clinic Near You
Who Is Running the Clinical Trial?
Innosphere
Lead Sponsor